esophageal cancer
Conditions
Interventions
Sponsors
Peking University Cancer Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Adult patients diagnosed with esophageal cancer and scheduled for elective minimally invasive Mckeown esophagectomy via thoracoscopy and laparoscopy between Janurary 2016 and February 2023 were enrolled.
Exclusion criteria
Exclusion criteria: Patients diagnosed with cervical esophageal cancer, patients with esophageal cancer recurrence, had an American Society of Anesthesiologists grade greater than class III, had COVID-19 a month prior to surgery or during hospitalization, with change of operation method during surgery (eg. unresectable tumors discovered during surgery/conversion of thoracoscopy or laparoscopy to an open procedure or with combined excision of other organs), and patients with missing data were excluded from the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| pneumonia occurring by postoperative day 7 after surgery;pleural effusion requiring additional drainage procedure by postoperative day 7;pneumothorax requiring treatment by postoperative day 7;atelectasis mucous pugging requiring bronchoscopy by postoperative day 7;respiratory failure by postoperative day 7;acute respiratory distress syndrome by postoperative day 7;acute aspiration by postoperative day 7;tracheobronchial injury by postoperative day 7; | — |
Secondary
| Measure | Time frame |
|---|---|
| non-pulmonary complications; | — |
Countries
China
Contacts
Public ContactHongyu Tan
Peking University Cancer Hospital
Outcome results
None listed